‘Unlimited’ Cancer Costs: The Medicare Part D Dilemma
One expert highlights the high cost of cancer drugs under Medicare Part D, and how somewhat arbitrary variations in a patient’s cancer type can lead to big differences in costs. Medscape Medical News …read more